Using Coherent Spectroscopy for Diagnosing Cancer at Its Early Stages

A new automated way of monitoring oncological diseases that combines forced luminescence and stimulated Brillouin scattering is proposed. Characteristics are studied of the transmission spectra of human colorectal (HT-29) and human cervical (HeLa) adenocarcinoma cells and tumor markers for PCR in water at the amounts needed for initial identification with 95% probability. The results are used to create a model of a device for monitoring oncology at its early stages.